3Famakinwa OM, Roman SA, Wang TS, et al. ATA practice guidelines for the treat- ment of differentiated thyroid cancer: were they followed in the United States? [J]. The American Journal of Surgery, 2010, 199(2): 189-198.
4Oqilvie JB, Patel KN, Heller KS, et al. Im- pact of the 2009 American Thyroid Associ- ation guidelines on the choice of operation for well-differentiated thyroid microcarcino- mas[J]. Surgery, 2010, 148(6): 1222-1227.
5Mazzaferri EL, Kloosr RT. Clinical review: Current approaches to Primary therapy for papilary and follicular thyroid cancer [J]. J Clin Endocrinol Metab, 2001, 86(4): 1447- 1463.
6Anastasiou OE, Yavropoulou MP, Pa- pavramidis TS, et al. Secretory Capacity of the Parathyroid Glands after Total Thy- roidectomy in Normocalcemic Subjects [J]. Journal of Clinical Endocrinology & Metabolism ([Epub ahead of print]), 2012: 1170.
7Lo GY, Tam SC. Tam. Parathyroid auto- transplantation during thyroidectomy [J]. Arch Surg, 2001, 136(12): 1381-1385.
8De Sanctis V, Soliman A, Fiscina B. Hypoparathyroidism:fromdiagnosis to treatment [J ]. Curt Opin Endocrinol Diabetes Obes, 2012,19(6):435-442.
9Youngwirth L, Benavidez J, Sippel R, et al. Parathyroid hormone deficiency after total thyroideetomy:incidenee and time [J]. J Surg Res,2010,163( 1 ) :69-71.
10Horwitz M J, Stewart AF. Hypoparathyroidism:is it time for re- placement therapy? [J]. J Clin Endocrinol Metab, 2008, 93(9): 3307-3309.
